People | June 13, 2025
Sun Pharma appoints Kirti Ganorkar as the Managing Director
Dilip Shanghvi to continue as the Executive Chairman of the Board
Dilip Shanghvi to continue as the Executive Chairman of the Board
Adjusted EBITDA positive at Rs. 3.1 crore despite investments in marketing, talent hiring and technology over the year
YESINTEK is indicated for the treatment of adults and children from the age of 6 years and olde
Orion will be the exclusive partner for the distribution, marketing, and sales of Shilpa's Recombinant Human Albumin in Europe
Record international participation reflects renewed momentum in pharma manufacturing and global sourcing, as easing tariffs fuel growth
The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025
EBITDA for the period rose by 23.2% to Rs. 3,797 million
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
She has held senior positions at Coca-Cola in China and PepsiCo in India
EBITDA before special items decreases to €4.08 billion (7.4%)
Subscribe To Our Newsletter & Stay Updated
